Madrigal Pharmaceuticals (FRA:YDO1) Price-to-Operating-Cash-Flow

: (As of Today)

View and export this data going back to 2007. Start your Free Trial

As of today (2024-04-19), Madrigal Pharmaceuticals's share price is €208.30. Madrigal Pharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was €-16.13. Hence, Madrigal Pharmaceuticals's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Madrigal Pharmaceuticals's Price-to-Operating-Cash-Flow or its related term are showing as below:

FRA:YDO1's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 24.36
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Madrigal Pharmaceuticals's Cash Flow from Operations per share for the three months ended in Dec. 2023 was €-3.71. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was €-16.13.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -19.40% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -59.60% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 5.20% per year.

During the past 13 years, Madrigal Pharmaceuticals's highest 3-Year average Operating Cash Flow per Share Growth Rate was 59.80% per year. The lowest was -86.20% per year. And the median was 5.50% per year.

Madrigal Pharmaceuticals Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Madrigal Pharmaceuticals's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Madrigal Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Madrigal Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Operating-Cash-Flow																-	-	-	-	-

Competitive Comparison

For the Biotechnology subindustry, Madrigal Pharmaceuticals's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Madrigal Pharmaceuticals Price-to-Operating-Cash-Flow Distribution

For the Biotechnology industry and Healthcare sector, Madrigal Pharmaceuticals's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Madrigal Pharmaceuticals's Price-to-Operating-Cash-Flow falls into.

Madrigal Pharmaceuticals Price-to-Operating-Cash-Flow Calculation

Madrigal Pharmaceuticals's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	208.30	/	-16.127
	=

Madrigal Pharmaceuticals's Share Price of today is €208.30.
Madrigal Pharmaceuticals's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-16.13.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Madrigal Pharmaceuticals Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Madrigal Pharmaceuticals's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Madrigal Pharmaceuticals (FRA:YDO1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Madrigal Pharmaceuticals Inc (FRA:YDO1) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

MDGL:USA

Address

200 Barr Harbor Drive, Suite 200, Four Tower Bridge, West Conshohocken, PA, USA, 19428

Website

http://www.madrigalpharma.com

Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed B-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Also, MGL-3196 reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action.

Madrigal Pharmaceuticals (FRA:YDO1) Headlines

No Headlines